Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.00
-0.28 (-3.02%)
Jun 27, 2025, 4:00 PM - Market closed
Zevra Therapeutics Employees
Zevra Therapeutics had 59 employees as of December 31, 2024. The number of employees decreased by 10 or -14.49% compared to the previous year.
Employees
59
Change (1Y)
-10
Growth (1Y)
-14.49%
Revenue / Employee
$687,932
Profits / Employee
-$1,559,119
Market Cap
492.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZVRA News
- 4 weeks ago - Zevra Announces Final Results of 2025 Annual Meeting of Stockholders - GlobeNewsWire
- 5 weeks ago - All Three Leading Proxy Advisory Firms – ISS, Glass Lewis, and Egan-Jones – Recommend Zevra Stockholders Vote FOR the Company's Director Nominees - GlobeNewsWire
- 6 weeks ago - Zevra Therapeutics, Inc. (ZVRA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call - GlobeNewsWire
- 2 months ago - Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism - GlobeNewsWire
- 2 months ago - Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million - GlobeNewsWire
- 3 months ago - Zevra Therapeutics Files Preliminary Proxy - GlobeNewsWire
- 3 months ago - Zevra Therapeutics, Inc. (ZVRA) Q4 2024 Earnings Call Transcript - Seeking Alpha